SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-130683
Filing Date
2023-05-01
Accepted
2023-05-01 17:10:57
Documents
12
Period of Report
2023-04-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d477272d8k.htm   iXBRL 8-K 22750
  Complete submission text file 0001193125-23-130683.txt   147363

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sppi-20230425.xsd EX-101.SCH 2834
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE sppi-20230425_lab.xml EX-101.LAB 18756
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sppi-20230425_pre.xml EX-101.PRE 11699
6 EXTRACTED XBRL INSTANCE DOCUMENT d477272d8k_htm.xml XML 3530
Mailing Address 11500 S. EASTERN AVE., SUITE 240 HENDERSON NV 89052
Business Address 11500 S. EASTERN AVE., SUITE 240 HENDERSON NV 89052 702-835-6300
SPECTRUM PHARMACEUTICALS INC (Filer) CIK: 0000831547 (see all company filings)

IRS No.: 930979187 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35006 | Film No.: 23874959
SIC: 2834 Pharmaceutical Preparations